Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Chronic kidney disease is common after heart transplantation, and is related to ciclosporin
(CsA) therapy. We compared the safety and efficacy of two ciclosporin withdrawal regimens.